Susan Galbraith, MD, PhD, provides an overview of the ongoing phase I/II AURA study.
Susan Galbraith, MD, PhD
Advertisement
Articles by Susan Galbraith, MD, PhD
Advertisement
Latest Updated Articles
AZD9291 in Advanced NSCLCPublished: November 10th 2014 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
